Cross-Sector entity

DEA

government
6.7

Of the tracked stories, 2 of 3 also mention FIDO Alliance, the most common co-covered peer. Across an 8-day span, the pace is roughly 2.6 stories per week. The busiest single day carried 2. health-it accounts for 1 of the 3 tracked stories, while 2 other categories carry the remainder.

3 verified stories tracked

Last mentioned: Mar 17, 2026

Entity pulse

Recent coverage · DEA

3 stories
6.7 avg impact
67% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 67 percentage points.

  • 67% positive
  • 33% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about DEA

Of the tracked stories, 2 of 3 also mention FIDO Alliance, the most common co-covered peer. Across an 8-day span, the pace is roughly 2.6 stories per week. The busiest single day carried 2. health-it accounts for 1 of the 3 tracked stories, while 2 other categories carry the remainder. The tracked stories average 2 original sources each. DEA appears in 3 tracked Cross-Sector stories published from March 10, 2026 through March 17, 2026.

Stories tracked
3
Per week
2.6
Sources per story
2

Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering DEA. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Litigation Wave

    Expected increase in consumer protection lawsuits regarding cannabis health claims.

  2. State Regulatory Review

    State health departments begin formal reviews of medical marijuana qualifying conditions.

  3. National Media Coverage

    CNN and 6abc report on the findings, sparking industry-wide debate.

  4. Scientific Report Published

    Comprehensive study on cannabis and mental health efficacy released to the public.

Stories mentioning DEA 3

Legal regulation Neutral 6

Scientific Consensus Challenges Medical Marijuana Efficacy for Mental Health

New scientific findings indicate that marijuana does not effectively treat anxiety or other mental health conditions, creating a significant regulatory and legal crisis for the medical cannabis industry. This development is expected to trigger a wave of consumer protection litigation and force state regulators to re-evaluate qualifying conditions for medical programs.

2 sources

Source: 6abc.com · us.cnn.com

Cyber security Positive 7

Passwordless Healthcare: Navigating the Shift to FIDO2 and Biometrics

The healthcare sector is accelerating its transition to passwordless authentication to combat rising credential-based attacks and clinician burnout. This shift requires balancing high-security FIDO2 standards with the constraints of legacy medical infrastructure and strict regulatory compliance.

2 sources